Bayer

U.S. Supreme Court asks for views of Solicitor General in Durnell case

30 Jun 2025

Eylea™ 8 mg with extended 6-month treatment interval approved in the EU

30 Jun 2025

CHMP recommends third indication for Bayer’s Nubeqa™ (darolutamide) for patients with advanced prostate cancer

20 Jun 2025

Bayer restructures Sustainability Council and appoints five new members

12 Jun 2025

Bayer and Broad Institute extend research collaboration to develop new cardiovascular therapies

11 Jun 2025

Simultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes

05 Jun 2025

Vividion Therapeutics and Bayer Further Strengthen Oncology Development Pipeline with Clinical-Stage WRN Inhibitor

04 Jun 2025

New tomato varieties from Bayer offer protection against resistance-breaking Tomato Brown Rugose Fruit Virus (ToBRFV)

04 Jun 2025

Articles tagged with 'seeds' | Bayer

04 Jun 2025

U.S. FDA approves third indication of Bayer blockbuster Nubeqa™ (darolutamide) for patients with advanced prostate cancer

04 Jun 2025

View details about the software product Informachine News Trackers